Novo Nordisk to present Wegovy and Ozempic data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025 ↗
European Commission approves IMBRUVIC (ibrutinib) as the first targeted therapy for patients with previously untreated mantle cell lymphoma who would be eligible for autologous stem cell transplant ↗